These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 9650754

  • 21. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
    Bukholm IK, Nesland JM.
    Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
    Ioachim EE, Katsanos KH, Michael MC, Tsianos EV, Agnantis NJ.
    Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
    [Abstract] [Full Text] [Related]

  • 23. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P, Stefanaki K, Vlachonikolis J, Eliopoulos G, Kakolyris S, Rontogianni D, Gorgoulis V, Georgoulias V.
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [Abstract] [Full Text] [Related]

  • 24. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.
    Clin Cancer Res; 2005 Jan 01; 11(1):267-72. PubMed ID: 15671555
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival.
    Hilton DA, Penney M, Evans B, Sanders H, Love S.
    Am J Surg Pathol; 2002 Apr 01; 26(4):472-8. PubMed ID: 11914625
    [Abstract] [Full Text] [Related]

  • 26. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
    Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T, Sasaki K.
    Cancer Lett; 2001 Sep 20; 170(2):183-9. PubMed ID: 11463497
    [Abstract] [Full Text] [Related]

  • 27. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ, Pekola TT, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.
    J Clin Pathol; 2003 Mar 20; 56(3):214-20. PubMed ID: 12610102
    [Abstract] [Full Text] [Related]

  • 28. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J, Estes ML, Drazba JA, Liu H, Prayson R, Kondo S, Jacobs BS, Barnett GH, Barna BP.
    Oncogene; 2000 Feb 03; 19(5):661-9. PubMed ID: 10698511
    [Abstract] [Full Text] [Related]

  • 29. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ, Liang LZ, Li DC, Li JL, Zhang CQ, Yuan SH.
    Ai Zheng; 2004 Jan 03; 23(1):74-80. PubMed ID: 14720380
    [Abstract] [Full Text] [Related]

  • 30. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression.
    Ono Y, Tamiya T, Ichikawa T, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S, Ueki K, Louis DN.
    Acta Neuropathol; 1997 Jul 03; 94(1):21-7. PubMed ID: 9224526
    [Abstract] [Full Text] [Related]

  • 31. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J, Blomqvist C, Heikkilä P, Boguslawski KV, Räisänen-Sokolowski A, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E.
    Clin Cancer Res; 2000 Aug 03; 6(8):3103-10. PubMed ID: 10955790
    [Abstract] [Full Text] [Related]

  • 32. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P, Stefanaki K, Rontogianni D, Papalazarou D, Sgantzos M, Arvanitis D, Vamvouka C, Gorgoulis V, Siatitsas I, Agnantis NJ, Bai M.
    Histol Histopathol; 2001 Oct 03; 16(4):1005-12. PubMed ID: 11642719
    [Abstract] [Full Text] [Related]

  • 33. Increased levels of p21WAF1/Cip1 in human brain tumors.
    Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W.
    Oncogene; 1995 Nov 16; 11(10):2021-8. PubMed ID: 7478521
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D, Jassem E, Jassem J, Karmoliński A, Lapiński M, Tomaszewski D, Rzyman W, Jaśkiewicz K, Sworczak K, Grossman AB.
    Lung Cancer; 2009 Oct 16; 66(1):127-33. PubMed ID: 19200616
    [Abstract] [Full Text] [Related]

  • 35. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP, Lin JW, Wang CC, Chiu YC, Huang CC, Chuah SK, Tai MH, Yi LN, Lee CM, Changchien CS, Hu TH.
    Oncol Rep; 2008 Jan 16; 19(1):49-56. PubMed ID: 18097575
    [Abstract] [Full Text] [Related]

  • 36. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer.
    Pinto AE, André S, Laranjeira C, Soares J.
    Pathology; 2005 Feb 16; 37(1):45-50. PubMed ID: 15875733
    [Abstract] [Full Text] [Related]

  • 37. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
    Pasz-Walczak G, Kordek R, Faflik M.
    Pathol Res Pract; 2001 Feb 16; 197(10):683-9. PubMed ID: 11700890
    [Abstract] [Full Text] [Related]

  • 38. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
    Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T.
    Anticancer Res; 2000 Feb 16; 20(1A):345-9. PubMed ID: 10769678
    [Abstract] [Full Text] [Related]

  • 39. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
    Anttila MA, Kosma VM, Hongxiu J, Puolakka J, Juhola M, Saarikoski S, Syrjänen K.
    Br J Cancer; 1999 Apr 16; 79(11-12):1870-8. PubMed ID: 10206307
    [Abstract] [Full Text] [Related]

  • 40. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.